ADJUNCTIVE AUTOLOGOUS PLATELET-RICH PLASMA IN PERIODONTITIS TREATMENT: CLINICAL EVIDENCE, BIOLOGICAL RATIONALE, AND A STEPWISE DECISION FRAMEWORK
Keywords:
periodontitis; plasmolifting; platelet-rich plasma; injectable platelet-rich fibrin; autologous platelet concentrates; probing pocket depth; clinical attachment level; periodontal regeneration.Abstract
Background: Periodontitis is a biofilm-mediated inflammatory disease characterized by progressive loss of periodontal support. Autologous platelet concentrates, including platelet-rich plasma (PRP) and injectable platelet-rich fibrin (i-PRF), have been investigated as adjuncts to conventional therapy, but heterogeneity in preparation complicates interpretation. Objective: To critically assess the biological rationale, clinical effectiveness, and practical limitations of adjunctive platelet-concentrate treatment in periodontitis. Methods: A focused narrative synthesis was conducted using published periodontal guidelines, systematic reviews, and randomized-trial meta-analyses. Evidence was organized around probing pocket depth (PPD), clinical attachment level (CAL), bleeding on probing (BoP), biomaterial characteristics, and the position of adjunctive treatment within staged periodontal care. Results: A published 2025 meta-analysis of ten studies found additional PPD reductions of 0.62 mm (95% CI, 0.22–1.03) and CAL gains of 0.77 mm (95% CI, 0.37–1.18) at 6–12 weeks with autologous platelet concentrates as a class, compared with nonsurgical periodontal therapy alone. At six months, the corresponding improvements were 0.61 and 1.14 mm. However, high heterogeneity and very low certainty of evidence prevent attribution of these estimates to any single injectable PRP protocol. Conclusion: Platelet-derived adjuncts may offer modest clinical benefits in selected patients, but they do not replace biofilm control, risk-factor modification, or periodontal maintenance. Standardized preparation, adequate controls, and longer follow-up are essential before routine adoption.
References
1. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159–S172. doi:10.1002/JPER.18-0006.
2. Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47(Suppl 22):4–60. doi:10.1111/jcpe.13290.
3. Niemczyk W, Janik K, Żurek J, Skaba D, Wiench R. Platelet-Rich Plasma (PRP) and Injectable Platelet-Rich Fibrin (i-PRF) in the Non-Surgical Treatment of Periodontitis—A Systematic Review. Int J Mol Sci. 2024;25(12):6319. doi:10.3390/ijms25126319.
4. Lipovec T, Kapadia N, Antonoglou GN, Lu EMC, Fawzy El-Sayed KM, Nibali L. Autologous platelet concentrates as adjuncts to non-surgical periodontal therapy: a systematic review and meta-analysis. Clin Oral Investig. 2025;29(1):74. doi:10.1007/s00784-024-06128-w.
5. Nik Eezammuddeen N, Johari NN, Demius O, Al-Bayaty FH. The effectiveness of autologous platelet-rich concentrates as an adjunct during nonsurgical periodontal therapy: a systematic review and meta-analysis of randomized controlled trials. Evid Based Dent. 2025;26:68. doi:10.1038/s41432-024-01060-0.
